Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Mayo Clinic
2,000 participants
Jan 16, 2017
INTERVENTIONAL
Conditions
Summary
This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant cancer associated genes and what they do. Finding genetic markers for pre-malignant conditions may help identify patients who are at risk of pre-myeloid cancers and bone marrow failure syndromes and lead to earlier intervention.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Undergo blood sample, hair follicle, and saliva collection
Undergo a bone marrow biopsy
Undergo a skin punch biopsy
Undergo a saliva or buccal swab
Undergo clinical assessment
Receive genetic counseling
Ancillary studies
Ancillary studies
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02958462